Search Results - "DOLCETTI, Riccardo"

Refine Results
  1. 1

    Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance by Budhwani, Megha, Mazzieri, Roberta, Dolcetti, Riccardo

    Published in Frontiers in oncology (21-08-2018)
    “…The efficacy of several therapeutic strategies against cancer, including cytotoxic drugs, radiotherapy, targeted immunotherapies and oncolytic viruses, depend…”
    Get full text
    Journal Article
  2. 2

    A lymphomagenic role for HIV beyond immune suppression? by Dolcetti, Riccardo, Gloghini, Annunziata, Caruso, Arnaldo, Carbone, Antonino

    Published in Blood (17-03-2016)
    “…Despite the immune reconstitution promoted by combined antiretroviral therapy (cART), lymphomas still represent the most common type of cancer in HIV-infected…”
    Get full text
    Journal Article
  3. 3

    Immunotherapy for Gastric Cancer: Time for a Personalized Approach? by Dolcetti, Riccardo, De Re, Valli, Canzonieri, Vincenzo

    “…Over the last decade, our understanding of the mechanisms underlying immune modulation has greatly improved, allowing for the development of multiple…”
    Get full text
    Journal Article
  4. 4

    Lymphomas occurring specifically in HIV-infected patients: From pathogenesis to pathology by Gloghini, Annunziata, Dolcetti, Riccardo, Carbone, Antonino

    Published in Seminars in cancer biology (01-12-2013)
    “…Abstract Lymphomas that develop in HIV positive patients are predominantly aggressive B-cell malignancies. The most common HIV-associated lymphomas are Burkitt…”
    Get full text
    Journal Article
  5. 5

    Proposed Molecular and miRNA Classification of Gastric Cancer by Alessandrini, Lara, Manchi, Melissa, De Re, Valli, Dolcetti, Riccardo, Canzonieri, Vincenzo

    “…Gastric cancer (GC) is a common malignant neoplasm worldwide and one of the main cause of cancer-related deaths. Despite some advances in therapies, long-term…”
    Get full text
    Journal Article
  6. 6

    Protein glycosylation in head and neck cancers: From diagnosis to treatment by Rasheduzzaman, Mohammad, Kulasinghe, Arutha, Dolcetti, Riccardo, Kenny, Liz, Johnson, Newell W., Kolarich, Daniel, Punyadeera, Chamindie

    “…Glycosylation is the most common post-translational modification (PTM) of proteins. Malignant tumour cells frequently undergo an alteration in surface protein…”
    Get full text
    Journal Article
  7. 7

    Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients by Cangemi, Michela, Montico, Barbara, Faè, Damiana A, Steffan, Agostino, Dolcetti, Riccardo

    Published in Frontiers in oncology (27-03-2019)
    “…malignancies constitute an emerging cause of morbidity after solid organ transplant (SOT), significantly affecting the long-term survival of transplant…”
    Get full text
    Journal Article
  8. 8

    Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications by Dolcetti, Riccardo, De Rossi, Anita

    Published in Medicinal research reviews (01-03-2012)
    “…Telomerase is a ribonucleoprotein complex critically involved in extending and maintaining telomeres. Unlike the majority of somatic cells, in which hTERT and…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis by Caselli, Elisabetta, Zatelli, Maria Chiara, Rizzo, Roberta, Benedetti, Sabrina, Martorelli, Debora, Trasforini, Giorgio, Cassai, Enzo, degli Uberti, Ettore C, Di Luca, Dario, Dolcetti, Riccardo

    Published in PLoS pathogens (01-10-2012)
    “…Hashimoto's thyroiditis (HT) is the most common of all thyroid diseases and is characterized by abundant lymphocyte infiltrate and thyroid impairment, caused…”
    Get full text
    Journal Article
  13. 13

    Reverse immunoediting: when immunity is edited by Antigen by Anna, Merlo, Silvia, Dalla Santa, Riccardo, Dolcetti, Zanovello, Paola, Antonio, Rosato

    Published in Immunology letters (01-07-2016)
    “…Highlights • The immune response sculpts tumor features through the immunoediting process. • In “reverse immunoediting”, a tumor or a foreign antigen shapes…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment by Carbone, Antonino, Gloghini, Annunziata, Pruneri, Giancarlo, Dolcetti, Riccardo

    Published in Cancer medicine (Malden, MA) (01-06-2019)
    “…Immune checkpoint‐blocking antibodies have therapeutic activity against relapsed or progressive classic Hodgkin lymphoma (cHL), but Hodgkin Reed‐Sternberg…”
    Get full text
    Journal Article
  16. 16

    B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation by Giagulli, Cinzia, Caccuri, Francesca, Zorzan, Simone, Bugatti, Antonella, Zani, Alberto, Filippini, Federica, Manocha, Ekta, D’Ursi, Pasqualina, Orro, Alessandro, Dolcetti, Riccardo, Caruso, Arnaldo

    Published in Cancer gene therapy (01-06-2021)
    “…Combined antiretroviral therapy (cART) for HIV-1 dramatically slows disease progression among HIV + individuals. Currently, lymphoma represents the main cause…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models by Moi, Davide, Zeng, Bijun, Minnie, Simone A, Bhatt, Rituparna, Wood, Jack, Sester, David P, Mazzieri, Roberta, Dolcetti, Riccardo

    Published in Frontiers in immunology (06-04-2023)
    “…Suitable methods to assess immunogenicity and therapeutic efficacy of cancer vaccines in preclinical cancer models are critical to overcome current limitations…”
    Get full text
    Journal Article
  19. 19

    Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies by Fratta, Elisabetta, Montico, Barbara, Rizzo, Aurora, Colizzi, Francesca, Sigalotti, Luca, Dolcetti, Riccardo

    Published in Oncotarget (30-08-2016)
    “…In recent years, recurrent somatic mutations in epigenetic regulators have been identified in patients with hematological malignancies. Furthermore,…”
    Get full text
    Journal Article
  20. 20

    Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma by Mastorci, Katy, Muraro, Elena, Pasini, Elisa, Furlan, Chiara, Sigalotti, Luca, Cinco, Marina, Dolcetti, Riccardo, Fratta, Elisabetta

    Published in PloS one (28-04-2016)
    “…Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin's lymphoma with a still undefined etiology. Several lines of evidence are consistent with the…”
    Get full text
    Journal Article